@tojiexperience's testosterone fat loss claims, fact-checked

What did @tojiexperience actually say?

The creator's core argument is that if you're overweight, depressed, and can't function, the benefits of starting TRT may outweigh the risks, even though high body fat amplifies side effects. He said he had "cognitive issues," "brain fog," and "zero motivation" before starting, and credits TRT with giving him the drive to improve his diet and exercise habits. He also gave a specific piece of advice: get bloodwork before you start, then recheck at six weeks to monitor estradiol, prolactin, hematocrit, and organ markers. He was notably honest that "your estrogen is gonna go up, your blood pressure might go up," and that supplements can help manage those effects. He also told viewers with more time and lower stakes to lose fat first before starting TRT. That's a more nuanced take than most TRT TikToks, and it's worth acknowledging before picking it apart.

Does the science back this up?

The aromatization concern is real and well-documented. The advice to try lifestyle changes first if you're functional is also grounded in evidence. But calling TRT "the best antidepressant out there" is a significant overreach that the research does not support at that level of certainty.

Adipose tissue contains aromatase, the enzyme that converts testosterone to estradiol. Higher body fat means more aromatase activity, so men with obesity starting TRT do experience greater estrogen elevation. This is documented in clinical endocrinology literature and is not controversial (Schneider et al., 2019, Journal of Clinical Endocrinology and Metabolism). The hematocrit risk is also real. TRT consistently raises red blood cell mass, and baseline cardiovascular risk in obese men compounds this (Golds et al., 2017, Endocrine Reviews).

On the depression claim, a 2023 randomized controlled trial published in NEJM (Lincoff et al.) showed testosterone treatment improved sexual function and some energy measures, but it was not a depression treatment trial. The evidence for TRT as a primary antidepressant is weak outside of men with confirmed hypogonadism, and even then the effect sizes are modest compared to established treatments (Amanatkar et al., 2014, Current Psychiatry Reports).

What did they get wrong (or right)?

He got the physiology broadly right and the lifestyle-first recommendation right. The "best antidepressant" framing is where things go sideways.

Credit where it's due: he correctly identified that aromatization increases with body fat, that prolactin and hematocrit can rise, and that monitoring bloodwork is non-negotiable. The recommendation to get labs before starting and six weeks in is consistent with clinical guidelines from the American Urological Association. He also correctly said that if you're "still functional" and have time, lose the fat first. That is the clinically supported path.

Where he went wrong: "the best antidepressant out there" is not a supportable claim. TRT is not approved as an antidepressant, and recommending it as such to a general TikTok audience, many of whom may have clinical depression requiring proper psychiatric care, is irresponsible framing. His personal experience is valid. Generalizing it as a primary treatment for depression is not. He also suggested taking "supplements to combat side effects" without naming them, which could lead viewers toward unmonitored self-management of serious hormonal changes.

What should you actually know?

If you're overweight and have low testosterone symptoms, the clinical guidance is clear: lifestyle changes first, TRT only if testosterone remains genuinely low after that, and always under physician supervision.

A 2016 study in European Journal of Endocrinology (Corona et al.) found that weight loss alone can significantly raise testosterone in obese men, sometimes into normal ranges. That means some men who think they need TRT actually need a caloric deficit. This does not mean TRT is wrong for everyone with high body fat, but it means you should rule out reversible causes before committing to a long-term hormonal intervention with real cardiovascular implications.

The six-week bloodwork check he recommends is reasonable but should include more than he listed. Standard monitoring includes total and free testosterone, estradiol, hematocrit, PSA, lipid panel, and blood pressure. Prolactin monitoring is less standard but not unreasonable depending on baseline. And "supplements to combat side effects" is not a substitute for physician-managed dose adjustments. If your estradiol is spiking, that is a conversation with your prescriber, not a supplement stack problem.

• TRT is FDA-approved for confirmed hypogonadism, not for general fatigue or low motivation in men with normal testosterone.
• If you have symptoms, get your testosterone tested first. Symptoms alone are not sufficient to diagnose hypogonadism.
• Hematocrit above 54% is a recognized threshold for dose reduction or treatment pause in clinical guidelines.